Gentris, Falco Partner to Create Japan's first GLP-Compliant PGx Lab | GenomeWeb
NEW YORK (GenomeWeb News) - Gentris has entered into an exclusive 10-year agreement with Kyoto-based Falco Biosystems to develop Japan’s first Good Laboratory Practice-compliant pharmacogenomics laboratory, Gentris announced today.
 
The partnership will be called “Gentris Japan.” Japan is the world’s second-largest pharmaceutical market after the US, Gentris said, adding drug companies in the country are increasingly looking to add pharmacogenomics into their drug-development programs.  
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.